Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Custom Search Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search
Updated Jun 05, 2024
| CHRS | Coherus BioSciences, Inc. | 114.00K | — | — | Jun 5, 2024 | Grant | — | 114.00K | — | Jun 4 | — | View | |
| CHRS | Coherus BioSciences, Inc. | 54.00K | — | — | Feb 22, 2024 | Grant | — | 54.00K | — | Feb 20 | — | View | |
| CHRS | Coherus BioSciences, Inc. | — | — | — | Feb 22, 2024 | — | — | — | — | Jan 12 | — | View | |
| — | Sierra Oncology, Inc. | -18.00K | — | — | Jul 1, 2022 | Disposition | -100.00% | — | — | Jul 1 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 115.00K | — | — | Feb 1, 2022 | Grant | — | 115.00K | Chief Financial Officer | Jan 28 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 115.00K | — | — | Nov 15, 2021 | Grant | — | 115.00K | Chief Financial Officer | Nov 11 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 10.30K | $8.10 | $83.43K | Sep 22, 2021 | Purchase | 115.54% | 98.21K | Chief Financial Officer | Sep 22 | — | View | |
| — | Sierra Oncology, Inc. | 18.00K | — | — | Jun 4, 2021 | Grant | — | 18.00K | — | Jun 2 | — | View | |
| — | Sierra Oncology, Inc. | — | — | — | Jun 3, 2021 | — | — | — | — | Jan 12 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | — | $2.12 | $53.00K | Feb 18, 2021 | Options | — | 233.82K | Chief Financial Officer | Feb 17 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 72.00K | — | — | Jan 29, 2021 | Grant | — | 72.00K | Chief Financial Officer | Jan 28 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 7.10K | $11.46 | $81.34K | Aug 20, 2020 | Purchase | 390.64% | 62.91K | Chief Financial Officer | Aug 18 - Aug 19 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 1.82K | $10.92 | $19.84K | Aug 4, 2020 | Purchase | — | 55.81K | Chief Financial Officer | Jul 31 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 52.16K | — | — | Feb 4, 2020 | Grant | — | 52.16K | Chief Financial Officer | Jan 31 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | 6.70K | $14.09 | $94.42K | Jan 23, 2020 | Purchase | — | 53.99K | Chief Financial Officer | Jan 21 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | — | $2.12 | $100.26K | Dec 6, 2019 | Options | — | 218.20K | Chief Financial Officer | Dec 4 | — | View | |
| ARTL | ARTELO BIOSCIENCES, INC. | 22.25K | — | — | Aug 30, 2019 | Grant | — | 22.25K | — | Jan 12 | — | View | |
| ARTL | ARTELO BIOSCIENCES, INC. | — | — | — | Jun 21, 2019 | — | — | 12.50K | — | Jan 12 | — | View | |
| HARP | Harpoon Therapeutics, Inc. | — | — | — | Feb 7, 2019 | — | — | — | Chief Financial Officer | Jan 12 | — | View | |
| — | Zosano Pharma Corp | 68.00K | $1.32 | $89.76K | May 25, 2017 | Purchase | 142.41% | 115.75K | CFO and Chief Business Officer | May 25 | — | View | |
| — | Zosano Pharma Corp | 252.00K | — | — | Sep 9, 2016 | Grant | — | 252.00K | CBO and Interim CFO | Sep 7 | — | View | |
| — | Zosano Pharma Corp | 143.25K | $0.73 | $74.97K | Aug 22, 2016 | Purchase | — | 143.25K | Interim CFO | Aug 19 | — | View | |
| — | Zosano Pharma Corp | — | — | — | Jun 24, 2016 | — | — | — | Interim CFO | Jan 12 | — | View | |
| — | Asterias Biotherapeutics, Inc. | 380.00K | — | — | Nov 12, 2015 | Grant | — | 380.00K | Exec VP & CFO | Nov 9 | — | View | |
| — | Asterias Biotherapeutics, Inc. | — | — | — | Nov 12, 2015 | — | — | — | Exec VP & CFO | Jan 12 | — | View | |
| — | Raptor Pharmaceutical Corp | 16.10K | $7.90 | $127.19K | May 15, 2014 | Purchase | — | 19.60K | Chief Financial Officer | May 13 | — | View | |
| — | Raptor Pharmaceutical Corp | 83.80K | — | — | Feb 11, 2014 | Grant | — | 83.80K | Chief Financial Officer | Feb 7 | — | View | |
| — | Raptor Pharmaceutical Corp | — | — | — | Feb 11, 2014 | — | — | 3.50K | Chief Financial Officer | Jan 12 | — | View | |
| — | Raptor Pharmaceutical Corp | -7.40K | $13.42 | -$99.33K | Sep 3, 2013 | Sale | -100.00% | — | Chief Financial Officer | Aug 30 | — | View | |
| — | Raptor Pharmaceutical Corp | 190.00K | — | — | Sep 12, 2012 | Grant | — | 190.00K | Chief Financial Officer | Sep 10 | — | View | |
| — | Raptor Pharmaceutical Corp | — | — | — | Sep 12, 2012 | — | — | 7.40K | Chief Financial Officer | Jan 12 | — | View |
Showing 31 results
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved